Literature DB >> 3780042

Affinity of human carcinoma cell nuclei for polyinosinic acid demonstrated by monoclonal antibodies.

J Jonsson, G Auer, K Erhardt, W Schilling, C Orvell, A Fagraeus.   

Abstract

The anti-nuclear cross reactivity of the monoclonal anti-actin antibodies M 372/809 was studied in some detail. The reactivity against a number of nuclear constituents was examined in the ELISA test and the capacities of these constituents to block the M 372/809 anti-nuclear and anti-actin reactions were evaluated in indirect immunofluorescence tests against tissue sections and monolayer cultures of fibroblasts and Vero cells. The repetitive polynucleotides polyinosinic and polyguanylic acid and their deoxyanalogues, actin and vimentin, were found to have the antigenic epitope. The epitope was covered or otherwise inactivated in the presence of polycytidylic acid. Using the M 372/809 antibodies as a reagent, carcinoma cell nuclei were found commonly to have an affinity for polyinosinic and polyguanylic acid. This was seldom noted with non-neoplastic cells.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3780042      PMCID: PMC1542509     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  16 in total

1.  Monoclonal anti-poly(rA) hybridoma antibodies from an autoimmune MRL/MpJ-lpr/lpr mouse.

Authors:  H Dang; M Fischbach; M Erdos; N Talal
Journal:  Clin Exp Immunol       Date:  1985-07       Impact factor: 4.330

2.  How much is secondary structure responsible for resistance of double-stranded RNA to pancreatic ribonuclease A?

Authors:  M Libonati; M Palmieri
Journal:  Biochim Biophys Acta       Date:  1978-04-27

3.  Role of the double-stranded nucleic acid backbone configuration in adsorption interactions.

Authors:  H G Martinson
Journal:  Biochemistry       Date:  1973-07-03       Impact factor: 3.162

4.  Cyclin: a nuclear protein whose level correlates directly with the proliferative state of normal as well as transformed cells.

Authors:  J E Celis; R Bravo; P M Larsen; S J Fey
Journal:  Leuk Res       Date:  1984       Impact factor: 3.156

5.  Monoclonal antibodies to epitopes shared by actin and vimentin obtained by paramyxovirus immunization.

Authors:  A Fagraeus; C Orvell; R Norberg; E Norrby
Journal:  Exp Cell Res       Date:  1983-05       Impact factor: 3.905

6.  Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation.

Authors:  J Gerdes; U Schwab; H Lemke; H Stein
Journal:  Int J Cancer       Date:  1983-01-15       Impact factor: 7.396

7.  Binding of cytoskeletal proteins by monoclonal anti-DNA lupus autoantibodies.

Authors:  J André-Schwartz; S K Datta; Y Shoenfeld; D A Isenberg; B D Stollar; R S Schwartz
Journal:  Clin Immunol Immunopathol       Date:  1984-05

8.  Polyspecific monoclonal lupus autoantibodies reactive with both polynucleotides and phospholipids.

Authors:  E M Lafer; J Rauch; C Andrzejewski; D Mudd; B Furie; B Furie; R S Schwartz; B D Stollar
Journal:  J Exp Med       Date:  1981-04-01       Impact factor: 14.307

9.  Polyspecificity of monoclonal lupus autoantibodies produced by human-human hybridomas.

Authors:  Y Shoenfeld; J Rauch; H Massicotte; S K Datta; J André-Schwartz; B D Stollar; R S Schwartz
Journal:  N Engl J Med       Date:  1983-02-24       Impact factor: 91.245

10.  Monoclonal antibodies specific for tight-binding human chromatin antigens reveal structural rearrangements within the nucleus during the cell cycle.

Authors:  J S Bhorjee; S L Barclay; A Wedrychowski; A M Smith
Journal:  J Cell Biol       Date:  1983-08       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.